- Home
- ZIMV vs CYRX Comparison
ZIMV vs CYRX Comparison
Compare ZIMV & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIMV
- CYRX
- Stock Information
- Founded
- ZIMV 2021
- CYRX 1999
- Country
- ZIMV United States
- CYRX United States
- Employees
- ZIMV N/A
- CYRX N/A
- Industry
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- ZIMV Health Care
- CYRX Health Care
- Exchange
- ZIMV Nasdaq
- CYRX Nasdaq
- Market Cap
- ZIMV 262.9M
- CYRX 310.4M
- IPO Year
- ZIMV N/A
- CYRX N/A
- Fundamental
- Price
- ZIMV $9.39
- CYRX $5.55
- Analyst Decision
- ZIMV Hold
- CYRX Strong Buy
- Analyst Count
- ZIMV 1
- CYRX 7
- Target Price
- ZIMV N/A
- CYRX $11.29
- AVG Volume (30 Days)
- ZIMV 155.1K
- CYRX 559.3K
- Earning Date
- ZIMV 05-07-2025
- CYRX 05-06-2025
- Dividend Yield
- ZIMV N/A
- CYRX N/A
- EPS Growth
- ZIMV N/A
- CYRX N/A
- EPS
- ZIMV N/A
- CYRX N/A
- Revenue
- ZIMV $449,749,000.00
- CYRX $228,385,000.00
- Revenue This Year
- ZIMV $1.90
- CYRX N/A
- Revenue Next Year
- ZIMV $2.61
- CYRX $5.30
- P/E Ratio
- ZIMV N/A
- CYRX N/A
- Revenue Growth
- ZIMV N/A
- CYRX N/A
- 52 Week Low
- ZIMV $8.56
- CYRX $4.58
- 52 Week High
- ZIMV $22.40
- CYRX $17.41
- Technical
- Relative Strength Index (RSI)
- ZIMV 33.02
- CYRX 46.04
- Support Level
- ZIMV $9.04
- CYRX $5.34
- Resistance Level
- ZIMV $9.52
- CYRX $5.97
- Average True Range (ATR)
- ZIMV 0.65
- CYRX 0.66
- MACD
- ZIMV 0.02
- CYRX 0.02
- Stochastic Oscillator
- ZIMV 35.39
- CYRX 38.82
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.